 | • レポートコード：GIR-105X14533 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、リセドロネートのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。リセドロネートの種類別市場規模（5mg錠、35mg錠、75mg錠、150mg錠）、用途別市場規模（閉経後骨粗鬆症、骨粗鬆症男性）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・リセドロネートの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Amgen、Teva、Mylan、Apotex、Sanofi、Abbott、Novartis、Tecoland、Taj Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：5mg錠、35mg錠、75mg錠、150mg錠 ・用途別分析2016年-2026年：閉経後骨粗鬆症、骨粗鬆症男性 ・リセドロネートの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・リセドロネートのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・リセドロネートのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・リセドロネートの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・リセドロネートの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Risedronate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Risedronate size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Risedronate market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Risedronate market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5 mg Tablets
35 mg Tablets
75 mg Tablets
150 mg Tablets
Market segment by Application can be divided into
Postmenopausal Osteoporosis
Men with Osteoporosis
The key market players for global Risedronate market are listed below:
Merck
Amgen
Teva
Mylan
Apotex
Sanofi
Abbott
Novartis
Tecoland
Taj Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Risedronate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Risedronate Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 5 mg Tablets
1.2.3 35 mg Tablets
1.2.4 75 mg Tablets
1.2.5 150 mg Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Risedronate Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Postmenopausal Osteoporosis
1.3.3 Men with Osteoporosis
1.4 Global Risedronate Market Size & Forecast
1.4.1 Global Risedronate Sales in Value (2016-2026))
1.4.2 Global Risedronate Sales in Volume (2016-2026)
1.4.3 Global Risedronate Price by Type (2016-2026) & (USD/Kg)
1.5 Global Risedronate Production Capacity Analysis
1.5.1 Global Risedronate Total Production Capacity (2016-2026)
1.5.2 Global Risedronate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Risedronate Market Drivers
1.6.2 Risedronate Market Restraints
1.6.3 Risedronate Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Risedronate Product and Services
2.1.4 Merck Risedronate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Risedronate Product and Services
2.2.4 Amgen Risedronate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Risedronate Product and Services
2.3.4 Teva Risedronate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Risedronate Product and Services
2.4.4 Mylan Risedronate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Apotex
2.5.1 Apotex Details
2.5.2 Apotex Major Business
2.5.3 Apotex Risedronate Product and Services
2.5.4 Apotex Risedronate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Risedronate Product and Services
2.6.4 Sanofi Risedronate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Risedronate Product and Services
2.7.4 Abbott Risedronate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Risedronate Product and Services
2.8.4 Novartis Risedronate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Tecoland
2.9.1 Tecoland Details
2.9.2 Tecoland Major Business
2.9.3 Tecoland Risedronate Product and Services
2.9.4 Tecoland Risedronate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Taj Pharmaceuticals
2.10.1 Taj Pharmaceuticals Details
2.10.2 Taj Pharmaceuticals Major Business
2.10.3 Taj Pharmaceuticals Risedronate Product and Services
2.10.4 Taj Pharmaceuticals Risedronate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Risedronate Sales by Manufacturer
3.1 Global Risedronate Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Risedronate Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Risedronate
3.4 Market Concentration Rate
3.4.1 Top 3 Risedronate Manufacturer Market Share
3.4.2 Top 6 Risedronate Manufacturer Market Share
3.5 Global Risedronate Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Risedronate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Risedronate Market Size by Region
4.1.1 Global Risedronate Sales in Volume by Region (2016-2026)
4.1.2 Global Risedronate Revenue by Region (2016-2026)
4.2 North America Risedronate Revenue (2016-2026)
4.3 Europe Risedronate Revenue (2016-2026)
4.4 Asia-Pacific Risedronate Revenue (2016-2026)
4.5 South America Risedronate Revenue (2016-2026)
4.6 Middle East and Africa Risedronate Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Risedronate Sales in Volume by Type (2016-2026)
5.2 Global Risedronate Revenue by Type (2016-2026)
5.3 Global Risedronate Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Risedronate Sales in Volume by Application (2016-2026)
6.2 Global Risedronate Revenue by Application (2016-2026)
6.3 Global Risedronate Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Risedronate Sales by Type (2016-2026)
7.2 North America Risedronate Sales by Application (2016-2026)
7.3 North America Risedronate Market Size by Country
7.3.1 North America Risedronate Sales in Volume by Country (2016-2026)
7.3.2 North America Risedronate Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Risedronate Sales by Type (2016-2026)
8.2 Europe Risedronate Sales by Application (2016-2026)
8.3 Europe Risedronate Market Size by Country
8.3.1 Europe Risedronate Sales in Volume by Country (2016-2026)
8.3.2 Europe Risedronate Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Risedronate Sales by Type (2016-2026)
9.2 Asia-Pacific Risedronate Sales by Application (2016-2026)
9.3 Asia-Pacific Risedronate Market Size by Region
9.3.1 Asia-Pacific Risedronate Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Risedronate Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Risedronate Sales by Type (2016-2026)
10.2 South America Risedronate Sales by Application (2016-2026)
10.3 South America Risedronate Market Size by Country
10.3.1 South America Risedronate Sales in Volume by Country (2016-2026)
10.3.2 South America Risedronate Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Risedronate Sales by Type (2016-2026)
11.2 Middle East & Africa Risedronate Sales by Application (2016-2026)
11.3 Middle East & Africa Risedronate Market Size by Country
11.3.1 Middle East & Africa Risedronate Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Risedronate Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Risedronate Typical Distributors
12.3 Risedronate Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Risedronate Revenue by Type, (USD Million), 2021-2026
Table 2. Global Risedronate Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Risedronate Product and Services
Table 6. Merck Risedronate Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Risedronate Product and Services
Table 10. Amgen Risedronate Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva Risedronate Product and Services
Table 14. Teva Risedronate Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Mylan Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Major Business
Table 17. Mylan Risedronate Product and Services
Table 18. Mylan Risedronate Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Apotex Basic Information, Manufacturing Base and Competitors
Table 20. Apotex Major Business
Table 21. Apotex Risedronate Product and Services
Table 22. Apotex Risedronate Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Risedronate Product and Services
Table 26. Sanofi Risedronate Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Abbott Basic Information, Manufacturing Base and Competitors
Table 28. Abbott Major Business
Table 29. Abbott Risedronate Product and Services
Table 30. Abbott Risedronate Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Risedronate Product and Services
Table 34. Novartis Risedronate Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Tecoland Basic Information, Manufacturing Base and Competitors
Table 36. Tecoland Major Business
Table 37. Tecoland Risedronate Product and Services
Table 38. Tecoland Risedronate Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Taj Pharmaceuticals Major Business
Table 41. Taj Pharmaceuticals Risedronate Product and Services
Table 42. Taj Pharmaceuticals Risedronate Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Risedronate Sales by Manufacturer (2019-2021e) & (MT)
Table 44. Global Risedronate Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Risedronate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Risedronate Production Capacity by Company, (MT): 2020 VS 2021
Table 47. Head Office and Risedronate Production Site of Key Manufacturer
Table 48. Global Risedronate Sales by Region (2016-2021e) & (MT)
Table 49. Global Risedronate Sales by Region (2021-2026) & (MT)
Table 50. Global Risedronate Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Risedronate Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Risedronate Sales by Type (2016-2021e) & (MT)
Table 53. Global Risedronate Sales by Type (2021-2026) & (MT)
Table 54. Global Risedronate Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Risedronate Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Risedronate Price by Type (2016-2021e) & (USD/Kg)
Table 57. Global Risedronate Price by Type (2021-2026) & (USD/Kg)
Table 58. Global Risedronate Sales by Application (2016-2021e) & (MT)
Table 59. Global Risedronate Sales by Application (2021-2026) & (MT)
Table 60. Global Risedronate Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Risedronate Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Risedronate Price by Application (2016-2021e) & (USD/Kg)
Table 63. Global Risedronate Price by Application (2021-2026) & (USD/Kg)
Table 64. North America Risedronate Sales by Country (2016-2021e) & (MT)
Table 65. North America Risedronate Sales by Country (2021-2026) & (MT)
Table 66. North America Risedronate Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Risedronate Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Risedronate Sales by Type (2016-2021e) & (MT)
Table 69. North America Risedronate Sales by Type (2021-2026) & (MT)
Table 70. North America Risedronate Sales by Application (2016-2021e) & (MT)
Table 71. North America Risedronate Sales by Application (2021-2026) & (MT)
Table 72. Europe Risedronate Sales by Country (2016-2021e) & (MT)
Table 73. Europe Risedronate Sales by Country (2021-2026) & (MT)
Table 74. Europe Risedronate Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Risedronate Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Risedronate Sales by Type (2016-2021e) & (MT)
Table 77. Europe Risedronate Sales by Type (2021-2026) & (MT)
Table 78. Europe Risedronate Sales by Application (2016-2021e) & (MT)
Table 79. Europe Risedronate Sales by Application (2021-2026) & (MT)
Table 80. Asia-Pacific Risedronate Sales by Region (2016-2021e) & (MT)
Table 81. Asia-Pacific Risedronate Sales by Region (2021-2026) & (MT)
Table 82. Asia-Pacific Risedronate Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Risedronate Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Risedronate Sales by Type (2016-2021e) & (MT)
Table 85. Asia-Pacific Risedronate Sales by Type (2021-2026) & (MT)
Table 86. Asia-Pacific Risedronate Sales by Application (2016-2021e) & (MT)
Table 87. Asia-Pacific Risedronate Sales by Application (2021-2026) & (MT)
Table 88. South America Risedronate Sales by Country (2016-2021e) & (MT)
Table 89. South America Risedronate Sales by Country (2021-2026) & (MT)
Table 90. South America Risedronate Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Risedronate Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Risedronate Sales by Type (2016-2021e) & (MT)
Table 93. South America Risedronate Sales by Type (2021-2026) & (MT)
Table 94. South America Risedronate Sales by Application (2016-2021e) & (MT)
Table 95. South America Risedronate Sales by Application (2021-2026) & (MT)
Table 96. Middle East & Africa Risedronate Sales by Country (2016-2021e) & (MT)
Table 97. Middle East & Africa Risedronate Sales by Country (2021-2026) & (MT)
Table 98. Middle East & Africa Risedronate Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Risedronate Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Risedronate Sales by Type (2016-2021e) & (MT)
Table 101. Middle East & Africa Risedronate Sales by Type (2021-2026) & (MT)
Table 102. Middle East & Africa Risedronate Sales by Application (2016-2021e) & (MT)
Table 103. Middle East & Africa Risedronate Sales by Application (2021-2026) & (MT)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Risedronate Typical Distributors
Table 107. Risedronate Typical Customers
List of Figures
Figure 1. Risedronate Picture
Figure 2. Global Risedronate Sales Market Share by Type in 2020
Figure 3. 5 mg Tablets
Figure 4. 35 mg Tablets
Figure 5. 75 mg Tablets
Figure 6. 150 mg Tablets
Figure 7. Global Risedronate Sales Market Share by Application in 2020
Figure 8. Postmenopausal Osteoporosis
Figure 9. Men with Osteoporosis
Figure 10. Global Risedronate Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 11. Global Risedronate Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Risedronate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Risedronate Sales (2016-2026) & (MT)
Figure 32. Global Risedronate Production Capacity (2016-2026) & (MT)
Figure 33. Global Risedronate Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Risedronate Market Drivers
Figure 35. Risedronate Market Restraints
Figure 36. Risedronate Market Trends
Figure 37. Global Risedronate Sales Market Share by Manufacturer in 2020
Figure 38. Global Risedronate Revenue Market Share by Manufacturer in 2020
Figure 39. Risedronate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Risedronate Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Risedronate Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Risedronate Sales Market Share by Region (2016-2026)
Figure 43. Global Risedronate Revenue Market Share by Region (2016-2026)
Figure 44. North America Risedronate Revenue (2016-2026) & (USD Million)
Figure 45. Europe Risedronate Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Risedronate Revenue (2016-2026) & (USD Million)
Figure 47. South America Risedronate Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Risedronate Revenue (2016-2026) & (USD Million)
Figure 49. Global Risedronate Sales Market Share by Type (2016-2026)
Figure 50. Global Risedronate Revenue Market Share by Type (2016-2026)
Figure 51. Global Risedronate Price by Type (2016-2026) & (USD/Kg)
Figure 52. Global Risedronate Sales Market Share by Application (2016-2026)
Figure 53. Global Risedronate Revenue Market Share by Application (2016-2026)
Figure 54. Global Risedronate Price by Application (2016-2026) & (USD/Kg)
Figure 55. North America Risedronate Sales Market Share by Country (2016-2026)
Figure 56. North America Risedronate Revenue Market Share by Country (2016-2026)
Figure 57. North America Risedronate Sales Market Share by Type (2016-2026)
Figure 58. North America Risedronate Sales Market Share by Application (2016-2026)
Figure 59. Europe Risedronate Sales Market Share by Country (2016-2026)
Figure 60. Europe Risedronate Revenue Market Share by Country (2016-2026)
Figure 61. Europe Risedronate Sales Market Share by Type (2016-2026)
Figure 62. Europe Risedronate Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Risedronate Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Risedronate Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Risedronate Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Risedronate Sales Market Share by Application (2016-2026)
Figure 67. South America Risedronate Sales Market Share by Country (2016-2026)
Figure 68. South America Risedronate Revenue Market Share by Country (2016-2026)
Figure 69. South America Risedronate Sales Market Share by Type (2016-2026)
Figure 70. South America Risedronate Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Risedronate Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Risedronate Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Risedronate Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Risedronate Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のエルトロンボパグ錠市場 2021：企業別、地域別、種類・用途別 The Eltrombopag Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 世界のカベルゴリン錠市場 2021：企業別、地域別、種類・用途別 The Cabergoline Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- タブレットジェスチャー認識の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Gesture recognition is the ability of a device to identify and respond to different gestures, such as movement of hands, fingers, arms, head, or the entire body, of an individual. Scope of the Report: This report studies the Gesture Recognition for Tablets market status and outlook of Global and maj…
- 世界のオフロキサシン錠市場 2021：企業別、地域別、種類・用途別 The Ofloxacin Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 塩化ベラプロストタブレットの世界市場2018-2025 In 2018, the global Beraprost Sodium Tablets market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Beraprost Sodium Tablets. T…